Observational studyBMC infectious diseases2026
Follow-up, diagnosis, and outcomes of fever of unknown origin cases in whom no diagnosis was established after initial evaluation: an ID-IRI (Infectious Diseases - International Research Initiative) observational retrospective cohort study.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimIn fever of unknown origin (FUO), despite comprehensive evaluation a substantial proportion of patients may remain without a definitive diagnosis. Herein, we aimed to analyse the disease course, mortality rate, final diagnosis, and the workup performed to reach final diagnosis in fever of unknown origin without final diagnoses (FUOWFD) cases. MATERIALS AND
methodsThe roster of patients with FUOWFD was obtained from a previously published multicenter study. Subsequently, additional data was gathered retrospectively from each cooperating center.
resultsThe follow-up data for 79 cases from 11 centers were included. While being considered as FUOWFD: 100% were performed biochemistry and microbiology, 78.5% for rheumatological markers, 33% for oncological markers, and 97.5% for radiological investigations. Other medical departments were consulted in 64.5% of the cases and invasive diagnostic procedures were performed in 27.8%. During the follow-up, 73 cases (92.4%) saw their fever resolve. Among these, 70 cases' fever resolved within the first three months. In total, two patients (2.5%) received a definitive diagnosis during the follow-up period. After 6 months and 12 months follow up, the all-cause mortality rate was 3.8%. Notably, none of the three cases that experienced mortality by day 365 had received a final diagnosis for FUO.
conclusionThe diagnostic process for FUO cases who remain undiagnosed exhibits substantial heterogeneity. The majority of patients experience spontaneous recovery, and the mortality rate is relatively low. Infectious causes are the most frequently encountered contributors to the FUO cases who remain undiagnosed. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.